foscarnet has been researched along with Hepatitis B, Chronic in 4 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effectiveness of foscarnet sodium in the treatment of severe chronic hepatitis B." | 9.12 | [Foscarnet sodium for treatment in patients with severe chronic hepatitis B]. ( Miao, XH; Si, CW; Yu, H; Yu, YY; Zhang, DZ; Zhou, XQ; Zhu, CL, 2006) |
| "To investigate the effectiveness of foscarnet sodium in the treatment of severe chronic hepatitis B." | 5.12 | [Foscarnet sodium for treatment in patients with severe chronic hepatitis B]. ( Miao, XH; Si, CW; Yu, H; Yu, YY; Zhang, DZ; Zhou, XQ; Zhu, CL, 2006) |
| " Combination therapy with Interferon-α and ribavirin remains the backbone treatment for chronic hepatitis C; the addition of serine protease inhibitors improves the treatment outcome of patients infected with hepatitis C virus genotype 1." | 4.87 | Antiviral drugs for viruses other than human immunodeficiency virus. ( Razonable, RR, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Razonable, RR | 1 |
| Han, YX | 1 |
| Xue, R | 1 |
| Zhao, W | 1 |
| Zhou, ZX | 1 |
| Li, JN | 1 |
| Chen, HS | 1 |
| Chen, XH | 1 |
| Wang, YL | 1 |
| Li, YH | 1 |
| Wu, YW | 1 |
| You, XF | 1 |
| Zhao, LX | 1 |
| Jiang, JD | 1 |
| Yu, YY | 1 |
| Zhang, DZ | 1 |
| Miao, XH | 1 |
| Zhu, CL | 1 |
| Zhou, XQ | 1 |
| Yu, H | 1 |
| Si, CW | 1 |
| Dumortier, J | 1 |
| Durupt, S | 1 |
| Chevallier, M | 1 |
| Trépo, C | 1 |
| Zoulim, F | 1 |
1 review available for foscarnet and Hepatitis B, Chronic
| Article | Year |
|---|---|
Antiviral drugs for viruses other than human immunodeficiency virus.
Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; | 2011 |
2 trials available for foscarnet and Hepatitis B, Chronic
| Article | Year |
|---|---|
Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.
Topics: Adult; Aged; Antiviral Agents; Cell Culture Techniques; Drug Therapy, Combination; Female; Foscarnet | 2005 |
[Foscarnet sodium for treatment in patients with severe chronic hepatitis B].
Topics: Adolescent; Adult; Antiviral Agents; Double-Blind Method; Female; Foscarnet; Hepatitis B, Chronic; H | 2006 |
1 other study available for foscarnet and Hepatitis B, Chronic
| Article | Year |
|---|---|
[Favorable course of hepatitis B virus reactivation with hepatocellular insufficiency by a treatment combining corticoids, foscarnet and ganciclovir].
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Glucocorticoids; | 1997 |